Sign in

CIK 0001005286

  • Accelerated filer
  • Smaller reporting company

LIFECORE BIOMEDICAL, INC. \DE\

Sign in to watch
Ticker
LFCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
May 25
Incorporated
DE
Entity type
Operating
EIN
943025618
Phone
+1 952-368-4300
Business address
3515 LYMAN BOULEVARD, CHASKA, MN, 55318
Former names
LANDEC CORP \CA\
  1. 4 Open-market buy 10% owner bought 240,587 shares at an average $10.02 ($2,410,360)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market buy Chief Financial Officer bought 2,000 shares at $10.18 ($20,360)
  4. 4/A Grant or award Chief People Officer acquired 18,608 shares (grant or award)
  5. 4 Grant or award Chief People Officer acquired 18,608 shares (grant or award)
  6. 4 Open-market buy Chief Financial Officer bought 1,400 shares at $11.88 ($16,632)
  7. 4 Open-market buy Chief Financial Officer bought 2,000 shares at $11.64 ($23,280)
  8. 4 Open-market buy Chief Financial Officer bought 2,000 shares at $12.06 ($24,120)
  9. 4 Open-market buy Chief Financial Officer bought 2,000 shares at $10.97 ($21,940)
  10. 4 Open-market buy Chief Financial Officer bought 2,000 shares at $10.87 ($21,740)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $10.98 ($109,800)
  14. 4 Open-market buy Director bought 20,000 shares at an average $10.76 ($215,248)
  15. 3/A Insider 3/A
  16. 4 Option exercise Chief Financial Officer acquired 5,000 shares (option exercise)
  17. 4 Grant or award Director acquired 2,200 shares (grant or award)
  18. 4 Grant or award Director acquired 7,334 shares (grant or award)
  19. 4 Grant or award Director acquired 2,200 shares (grant or award)
  20. 4 Grant or award Director acquired 2,200 shares (grant or award)

Page 9 of 47 · 936 filings